Ibex presents at the 2024 Future of Malaria Research Symposium at John Hopkins

Ibex invites you to click on the LinkedIn logo to subscribe to our news feed.

Ibex announces publication of Antibodies targeted to CD147 (patent pending)

Ibex receives a Top Biotechnology Start-up award for 2022 from Life Sciences Review Magazine.

Ibex announces publication of PCBP1 use for generating Stem Cells while inhibiting oncogenesis (patent pending)

Ibex announces completion of Phase 1 SBIR Grant

Ibex announces publication of FILAMIN-A (patent pending)

Ibex announces publication of PCBP1

Ibex announces SBIR award